RhumbLine Advisers’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
RhumbLine Advisers's RXST Position: Q1 2026 in Review
RhumbLine Advisers increased its RxSight (RXST) stake by 5.3% in Q1 2026, buying an estimated $19.1K and bringing the position to 46,175 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2930.
RhumbLine Advisers first reported a position in RXST in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.86M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- RhumbLine Advisers held 46,175 shares of RxSight worth $284K as of Q1 2026.
- RhumbLine Advisers bought 2,305 RxSight shares in Q1 2026, an estimated $19.1K.
- RxSight made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2930 holding.
- RhumbLine Advisers first reported a position in RxSight in Q1 2022 and has held it in 17 quarters since.
- RhumbLine Advisers's RxSight position peaked at $2.86M in Q2 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.